Analysis of drug resistance determinants in Klebsiella pneumoniae isolates from a tertiary-care hospital in Beijing, China

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Li, Bin ^a,b   Yi, Yong ^c   Wang, Qi ^a   Woo, Patrick C Y ^d   Tan, Lin ^a   Jing, Hua ^c   Gao, George F ^a   Liu, Cui Hua ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

^c 306 HOSPITAL OF PLA   (China)

^d THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; SODIUM AZIDE; SULTAMICILLIN; TOBRAMYCIN;

AACA4 GENE; AACC2 GENE; AADA1 GENE; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATE; BLACTX M 10 GENE; CHILD; CHINA; DHFR GENE; DRUG RESISTANCE; ESCHERICHIA COLI; EXTENSIVE DRUG RESISTANCE; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; QNRS GENE; SEQUENCE ANALYSIS; TERTIARY HEALTH CARE;

BASE SEQUENCE; CHINA; DNA PRIMERS; DRUG RESISTANCE, BACTERIAL; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHYLOGENY; POLYMERASE CHAIN REACTION; TERTIARY CARE CENTERS;

ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 84864457105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042280     Document Type: Article

References (65)

1. Sánchez-Romero I, Asensio A, Oteo J, Muñoz-Algarra M, Isidoro B, et al. (2012) Nosocomial Outbreak of VIM-1-producing Klebsiella pneumoniae of multilocus sequence type 15: Molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 56: 420-427.
2. Jemima SA, Verghese S, (2008) Molecular characterization of nosocomial CTX-M type β-lactamase producing Enterobacteriaceae from a tertiary care hospital in south India. Indian J Med Microbiol 4: 365-368.
3. Ko KS, Lee MY, Song JH, Lee H, Jung DS, et al. (2008) Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals. Diagn Microbiol Infect Dis 61: 453-459.
4. Kohlenberg A, Schwab F, Rüden H, (2012) Wide dissemination of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella spp. in acute care and rehabilitation hospitals Epidemiol Infect 140: 528-534.
5. Ptout JD, (2008) Multidrug resistant enterobacteriaceae: new threat of an old problem. Expert Rev Anti Infect Ther 6: 657-669.
6. Zhang R, Wang XD, Cai JC, Zhou HW, Lv HX, et al. (2011) Outbreak of Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae with high qnr prevalence in a Chinese hospital J Med Microbiol. 60: 977-982.
7. Bush K, Jacoby GA, (2010) Updated Functional Classification of β-Lactamases. Antimicrob Agents Chemother 54: 969-976.
8. Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, et al. (2004) Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 β-Lactamases in New York City. Clin Infect Dis 39: 55-60.
9. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, et al. (2011) Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 55: 1274-1278.
10. Chmelnitsky I, Carmeli Y, Leavitt A, Schwaber MJ, Navon-Venezia S, (2005) CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 49: 4745-4750.
11. Chudácková E, Bergerová T, Fajfrlík K, Cervená D, Urbásková P, et al. (2010) Carbapenem-nonsusceptible strains of Klebsiella pneumoniae producing SHV-5 and/or DHA-1 beta-lactamases in a Czech hospital. FEMS Microbiol Lett 309: 62-70.
12. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P, (2011) Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55: 2420-2423.
13. Hammerum AM, Toleman MA, Hansen F, Kristensen B, Lester CH, et al. (2010) Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis 10: 829-830.
14. Jean SS, Hsueh PR, Lee WS, Chang HT, Chou MY, et al. (2009) Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan. Eur J Clin Microbiol Infect Dis 28: 215-220.
15. Leavitt A, Chmelnitsky I, Ofek I, Carmeli Y, Navon-Venezia S, (2009) Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. J Antimicrob Chemother 65: 243-248.
16. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y, (2008) Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother 52: 1413-1418.
17. Nordmann P, Naas T, Poirel L, (2011) Global Spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17: 1791-1798.
18. Thomson KS, (2010) Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol 48: 1019-1025.
19. Ben-David D, Kordevani R, Keller N, Tal I, Marzel A, et al. (2012) Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 18: 54-60.
20. Daikos GL, Petrikkos P, Psichogiou M, Kosmidis C, Vryonis E, et al. (2009) Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 53: 1868-1873.
21. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO, (2001) Extended-spectrumβ-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32: 1162-1171.
22. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, et al. (2010) National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 54: 5099-5104.
23. Reinert RR, (2007) Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 60: 1818-1829.
24. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18: 268-281.
25. Clinical and Laboratory Standards Institute (CLSI) (2011) Performance Standards for antimicrobial Susceptibility Testing; Twenty-first Informational Supplement. CLSI document M100-S21.
26. Jacoby GA, Han P, (1996) Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34: 908-911.
27. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD, (2006) High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrob Agents Chemother 50: 3396-3406.
28. Robicsek A, Sahm DF, Strahilevitz J, Jacoby GA, Hooper DC, (2005) Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob Agents Chemother 49: 3001-3003.
29. Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM, (1996) Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases. Antimicrob Agents Chemother 40: 509-513.
30. Oliver A, Pérez-Díaz JC, Coque TM, Baquero F, Cantón R, (2001) Nucleotide Sequence and Characterization of a Novel Cefotaxime-Hydrolyzing beta-Lactamase (CTX-M-10) Isolated in Spain. Antimicrob Agents Chemother 45: 616-620.
31. Sabaté M, Tarragó R, Navarro F, Miró E, Vergés C, et al. (2000) Cloning and sequence of the gene rncoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob Agents Chemother 44: 1970-1973.
32. Schlesinger J, Navon-Venezia S, Chmelnitsky I, Hammer-Münz O, Leavitt A, et al. (2005) Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel. Antimicrob Agents Chemother 49: 1150-1156.
33. Cavaco LM, Hasman H, Xia S, Aarestrup FM, (2009) qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 53: 603-608.
34. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, et al. (2009) Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period. Antimicrob Agents Chemother 53: 639-645.
35. Park CH, Robicsek A, Jacoby GA, Sahm D, Hooper DC, (2006) Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50: 3953-3955.
36. Yamane K, Wachino J, Suzuki S, Kimura K, Shibata N, et al. (2007) New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob Agents Chemother 51: 3354-3360.
37. Zimhony O, Chmelnitsky I, Bardenstein R, Goland S, Hammer Muntz O, et al. (2006) Endocarditis caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility. Antimicrob Agents Chemother 50: 3179-3182.
38. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, et al. (2006) Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50: 4114-4123.
39. Ramirez MS, Tolmasky ME, (2010) Aminoglycoside modifying enzymes. Drug Resist Updat 13: 151-171.
40. Wang XR, Chen JC, Kang Y, Jiang N, An SC, et al. (2012) Prevalence and characterization of plasmid-mediated blaESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniae in patients with pneumonia. Chin Med J (Engl) 125: 894-900.
41. Younes A, Hamouda A, Dave J, Amyes SG, (2011) Prevalence of transferable blaCTX-M-15 from hospital- and community-acquired Klebsiella pneumoniae isolates in Scotland. J Antimicrob Chemother 66: 313-318.
42. Luo Y, Yang J, Zhang Y, Ye L, Wang L, et al. (2011) Prevalence of β-lactamases and 16S rRNA methylase genes amongst clinical Klebsiella pneumoniae isolates carrying plasmid-mediated quinolone resistance determinants. Int J Antimicrob Agents 37: 352-325.
43. Lee YH, Cho B, Bae IK, Chang CL, Jeong SH, (2006) Klebsiella pneumoniae strains carrying the chromosomal SHV-11 beta-lactamase gene produce the plasmid-mediated SHV-12 extended-spectrum beta-lactamase more frequently than those carrying the chromosomal SHV-1 beta-lactamase gene. J Antimicrob Chemother. 57: 1259-1261.
44. Veras DL, Alves LC, Brayner FA, Guedes DR, Maciel MA, et al. (2011) Prevalence of the blaSHV gene in Klebsiella pneumoniae isolates obtained from hospital and community infections and from the microbiota of healthy individuals in Recife, Brazil. Curr Microbiol 62: 1610-1616.
45. Giakkoupi P, Xanthaki A, Kanelopoulou M, Vlahaki A, Miriagou V, et al. (2003) VIM-1 Metallo-β-Lactamase-Producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41: 3893-3896.
46. Poulou A, Spanakis N, Pournaras S, Pitiriga V, Ranellou K, et al. (2010) Recurrent health-care-associated community-onset infections due to Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase. J Antimicrob Chemother 65: 2538-2542.
47. Tato M, Morosini M, García L, Albertí S, Coque MT, et al. (2010) Carbapenem heteroresistance in VIM-1-producing Klebsiella pneumoniae isolates belonging to the same clone: consequences for routine susceptibility testing. J Clin Microbiol 48: 4089-4093.
48. Goren MG, Chmelnitsky I, Carmeli Y, Navon-Venezia S, (2011) Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel. J Antimicrob Chemother 66: 672-673.
49. Poirel L, Héritier C, Tolün V, Nordmann P, (2004) Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48: 15-22.
50. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan,and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
51. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR, (2010) How To Detect NDM-1 Producers. J Clin Microbiol 49: 718-721.
52. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, et al. (2009) Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53: 5046-5054.
53. Deguchi T, Fukuoka A, Yasuda M, Nakano M, Ozeki S, et al. (1997) Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 41: 699-701.
54. Weigel LM, Steward CD, Tenover FC, (1998) gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob Agents Chemother 42: 2661-2667.
55. Aathithan S, French GL, (2010) Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance. Int J Antimicrob Agents 36: 239-242.
56. Bogaerts P, Galimand M, Bauraing C, Deplano A, Vanhoof R, et al. (2007) Emergence of ArmA and RmtB aminoglycoside resistance 16 S rRNA methylases in Belgium. J Antimicrob Chemother 59: 459-464.
57. Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, et al. (2009) Widespread dissemination of aminoglycoside resistance genes armA and rmtB in Klebsiella pneumoniae isolates in Taiwan producing CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 53: 104-111.
58. Schultsz C, Geerlings S, (2012) Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy. Drugs 72: 1-16.
59. Mokracka J, Koczura R, Pawlowski K, Kaznowski A, (2011) Resistance patterns and integron cassette arrays of the Enterobactercloacae complex strains of human origin. Med Microbiol 60: 737-743.
60. Moura A, Soares M, Pereira C, Leitão N, Henriques I, et al. (2009) INTEGRALL: a database and search engine for integrons, integrases and gene cassettes. Bioinformatics 25: 1096-1098.
61. Chmelnitsky I, Hermesh O, Navon-Venezia S, Strahilevitz J, Carmeli Y, (2009) Detection of aac(6′)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicro Chemother 64: 718-722.
62. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, et al. (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12: 83-88.
63. Bissonnette L, Roy PH, (1992) Characterization of In0 of Pseudomonas aeruginosa plasmid pVS1, an ancestor of integrons of multiresistance plasmids and transposons of gram-negative bacteria. J Bacteriol 174: 1248-1257.
64. Lee H, Yong D, Yum JH, Roh KH, Lee K, et al. (2006) Dissemination of 16S rRNA methylase-mediated highly amikacin-resistant isolates of Klebsiella pneumoniae and Acinetobacter baumannii in Korea. Diagn Microbiol Infect Dis 56: 305-312.
65. Pérez-Pérez FJ, Hanson ND, (2002) Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162.